Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Dermatological Treatment Volume 33, 2022 - Issue 3

Submit an article Journal homepage

Open access

2,699

Views

CrossRef citations to date

Altmetric

Articles

Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis

Steven R. Feldmana Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information

Joseph F. Merolab Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAView further author information

David M. Pariserc Eastern Virginia Medical School, Virginia Clinical Research, Inc, Norfolk, VA, USAView further author information

Jingchuan Zhangd Sun Pharmaceutical Industries Inc., Princeton, NJ, USAView further author information

Yang Zhaod Sun Pharmaceutical Industries Inc., Princeton, NJ, USAView further author information

Alan M. Mendelsohnd Sun Pharmaceutical Industries Inc., Princeton, NJ, USACorrespondence[email protected]
View further author information

Alice B. Gottliebe Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

show all

Pages 1670-1675 | Received 16 Feb 2021, Accepted 26 Feb 2021, Published online: 18 Mar 2021

Cite this article
https://doi.org/10.1080/09546634.2021.1898528
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (6)

Chang‐Yu Hsieh, Yu‐Hsian Tseng & Tsen‐Fang Tsai. (2023) Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis—A real‐word evidence from a 52‐week retrospective study. Experimental Dermatology 32:12, pages 2138-2148.
Crossref

Luca Mastorino, Sara Susca, Caterina Cariti, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Simone Ribero & Pietro Quaglino. (2022) “Superresponders” at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors . Experimental Dermatology 32:12, pages 2187-2188.
Crossref

Sarah E Thomas, Juul M P A van den Reek, Marieke M B Seyger & Elke M G J de Jong. (2023) How to define a ‘super-responder’ to biologics in psoriasis studies. British Journal of Dermatology 189:5, pages 621-622.
Crossref

Ricardo Ruiz-Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil & Manuel Galán-Gutiérrez. (2022) Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives. Life 12:9, pages 1412.
Crossref

Ricardo Ruiz-Villaverde, Javier Domínguez-Cruz, Francisco J. Navarro-Triviño, Manuel Galán-Gutiérrez, Jose Carlos Armario-Hita & Jose Juan Pereyra-Rodriguez. (2022) Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders). Life 12:8, pages 1192.
Crossref

Tom Macleod, Charles Bridgewood, Isabel Hyde, Megan Heague, Philip Helliwell, Martin Stacey & Miriam Wittmann. (2022) Molecular and cellular regulation of psoriatic inflammation. Clinical Science 136:12, pages 935-952.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references